News from NORD

Foundation for Prader-Willi Research Highlights Study of Genetic Therapy for Prader-Willi Syndrome

Publish date: February 17, 2017

 

The Foundation for Prader-Willi Research has published a blog that discusses a new study which shows promising first steps toward genetic therapy for Prader-Willi syndrome.

Recommended Reading

Rituximab is dramatically effective in IgG4-related disease
MDedge Endocrinology
NORD Seeks Input Regarding Patient Protections and ACA
MDedge Endocrinology
Rare Disease Day 2017 Will Highlight Research Theme
MDedge Endocrinology
NORD to Partner Again With Hole in the Wall Gang Camp
MDedge Endocrinology
Apply Now to Join NORD’s Charity Marathon Team
MDedge Endocrinology
CORD Offers Consensus Framework for Ethical Collaboration
MDedge Endocrinology
NORD Publishes Report on Spontaneous Intracranial Hypotension (SIH)
MDedge Endocrinology
Alport Syndrome Foundation Announces Research Funding
MDedge Endocrinology
Aplastic Anemia & MDS International Foundation Research Portal Is Open
MDedge Endocrinology
APS Type 1 Symposium Is Planned
MDedge Endocrinology